As investors gear up to navigate the ever-changing tides of the market, they seek out stocks with that extra oomph. Three companies appear to offer just that, making them prime choices for capitalizing on market momentum.
Soaring with Sarepta Therapeutics
Sarepta Therapeutics, Inc. (SRPT) has been making waves with a 14.6% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days. The company has earned itself a Zacks Rank #1 and exhibited a solid share price growth of 11.7% over the last month, outperforming the S&P 500’s advance of 4.3%. With a Momentum Score of A, Sarepta Therapeutics is clearly one to watch.
The Ascendancy of Wingstop Inc.
With a Zacks Rank #1 and a 2.1% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days, Wingstop Inc. (WING) has been soaring. The company’s shares have skyrocketed by 36.7% over the last three months, outpacing the S&P 500’s advance of 11.2%. Coupled with a Momentum Score of A, Wingstop Inc. is a top contender for investors.
Riding the Momentum with Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. (REGN) is riding the momentum with a 1.3% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days. The company’s shares have surged by 26.1% over the last six months, outshining the S&P 500’s advance of 7%. Possessing a Momentum Score of A, Regeneron Pharmaceuticals is poised to deliver substantial gains.
For investors seeking to ride the momentum, these stocks present strong opportunities for potential growth and healthy returns. Find out more here.
